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Abstract Objectives This paper reports on a pilot study
examining the incidence of nurses’ errors in preparation and
administration of intravenous drugs. Furthermore, the study
aimed to evaluate the short-term effects of implementation
of a new protocol for preparation and administration of
intravenous drugs. Setting Two nursing departments of
internal medicine at a 953 beds University Medical Centre
in The Netherlands. Methods By means of a prospective,
quasi-experimental design, nurses were observed during the
process of preparation and administration of intravenous
drugs. Observation was performed before and after the
implementation of a new protocol. Seventy-two nurses at
two nursing departments were observed during the study.
Main outcome measure A mean pre-test and post-test
quality score at two departments of internal medicine.
Results At baseline, average quality scores for nurses at the
two departments were 64 (intervention ward) and 67
(control ward) on a 0–100 quality scale. The pre-test quality
scores were not statistically significant for the two nursing
wards (T = 1.36, df = 55, P = 0.18). After the
implementation of the new protocol, nurses at the inter-
vention ward scored better (72) than nurses at the control
ward (69). The mean score at the intervention ward was
significantly higher than the score in nurses of the control
ward (T = -2.20, df = 53, P = 0.04). Conclusions The
number of errors in the preparation and administration of
intravenous drugs is high. This study shows that imple-
menting a protocol for the preparation and administration of
these drugs can reduce the number of errors.
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Impact of findings on practice
• Errors in preparation and administration of intravenous
drugs occur frequently and can cause irreparable dam-
age to patients.
• Errors in the preparation and administration of intrave-
nous drugs decrease significantly after implementation
of a protocol, leading to improved quality of care and
patient safety.
Introduction
Patient safety is an important issue in health care today. For
the USA it was estimated that more than a million injuries
and 44,000–98,000 deaths per year are related to subopti-
mal care or mistakes made by health care workers [1]. Yet,
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hospitalized patients are, as a rule, vulnerable and they
assume that health care will improve, rather than com-
promise, their health. Therefore, improving patient safety is
an important area for practice improvement as well as
research, and it covers a large variety of topics such as pre-
operative cardiac events, surgical items left in patients,
pressure ulcers, hospital acquired infections, falls and fall
injuries and delirium [2].
Adverse drug events are among the most common types
of health care errors [3–7]. In a study by Bates et al. 1% of
all adverse drug events were fatal, 12% were life threat-
ening, 30% were serious and 57% were significant [8]. In
the same study, 40% of all events were due to mistakes in
the process of administering drugs. The risk involved
seems especially high in the more complicated medication
administration processes, such as in the administration of
intravenous drugs.
The preparation and administration of intravenous drugs
is a series of complicated technical skills. The conse-
quences of medication preparation and administration
errors can be anything from relatively harmless to lethal.
Single site studies in the UK and USA confirm that nurses
make mistakes in preparing and administering intravenous
drugs in 13–84% of all cases [9, 10]. These studies used
different definitions for ‘errors’ in preparing and adminis-
tering intravenous drugs, thus making comparisons
difficult. The study of Taxis and Barber describes the dif-
ferent stages in the process in which errors occur, as well as
the clinical importance of these errors [11]. In this study,
one or more errors occurred in 49% of all cases of the
preparation and administration of intravenous drug doses.
Preparation errors occurred in 7%, administration errors
occurred in 36% and both types of errors were found in 6%
of all cases. 1% of these errors were potentially severe,
29% were potentially moderately harmful and 19% were
considered to be minor errors.
Examples of errors observed in practice and described in
studies are:
• administering a bolus dose too quickly;
• not inspecting the medicine for expiration date;
• not double-checking the prescribed drug, doses and
corresponding patient by a colleague;
• not observing hygiene regulations [11–13].
In conclusion, the evidence of quality and errors in the
preparation and administration of intravenous drugs is rather
scarce, but points towards a potentially problematic quality
of care issues. The study by Cousins et al. compares the
intravenous therapy protocols for hospitals in the UK,
Germany and France [12]. The study by Anselmi et al.
verified the frequency of errors in the preparation and
administration of intravenous drugs in three Brazilian hos-
pitals in the States of Bahia [14]. In all hospitals, various
difficulties in the developing and maintaining of intravenous
therapy protocols were identified. However, attempts to
improve the quality of the process of preparing and
administering intravenous drugs are minimal described
in the international literature [15, 16]. Yet, the quality of
this process is of vital importance in providing safe patient
care and attempts at quality improvement deserve to be
explored.
These clinical observations, and the motivation to
guarantee patient safety, were the reasons to examine the
quality and the effects of an attempt towards quality
improvement of the preparation and administration of
intravenous drugs in a Dutch academic hospital.
Aims of the study
The aims of the study were:
• To evaluate the quality of the preparation and admi-
nistration of intravenous drugs as performed by nurses
in general medicine hospital wards;
• To evaluate the effects of the implementation of a
protocol on the quality of the preparation and admi-
nistration of intravenous drugs.
Methods
The study employed a quantitative, prospective, quasi-
experimental design. The researcher observed the perfor-
mance of nurses during the process of preparation and
administration of intravenous drugs at two nursing
departments of internal medicine at a 953 beds University
Medical Centre in The Netherlands.
The study included data collection at baseline (pre-test:
8 weeks), an intervention period while the new protocol
was implemented in one of the two wards (2 weeks), and a
post-implementation test (post-test: 8 weeks). Nurses’
performance in the preparation and administration of drugs
was the main focus of the study.
Inclusion
Nurses were eligible for the study if:
• They were Registered Nurses at the departments of
internal medicine;
• They were fully qualified for the preparation and
administration of intravenous drugs;
• They declared themselves competent in the preparation
and administration of intravenous drugs;
• They gave permission for observation by the researcher.
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As nurses were also observed during the administration
of drugs, patient encounters were part of the observations.
Therefore, an additional inclusion criterion for the
observations was:
• Patients receiving drugs should (be able to) give
informed consent for the observations by the
researcher.
Protocol and observation list
A multidisciplinary team including two researchers, a
hospital pharmacist, a nurse practitioner, a ward nurse, an
infection control practitioner and an occupational hygienist
developed the new protocol, using the knowledge of
experts and the evidence from the scarce literature [17–19].
An observation list was directly derived from this protocol.
The observation list is a specification of the protocol and
consisted of 47 variables (Appendix). The variables re-
present the steps a nurse has to take in the preparation (30)
and administration (17) of intravenous drugs. Some of the
steps during the process of preparation and administration
had to be repeated more than once. All 47 aspects on the
list were observed during all occasions where nurses pre-
pared and administered intravenous drugs.
With the observation list the option ‘‘yes’’, ‘‘no’’, ‘‘not
applicable’’ or ‘‘missing’’ could be checked. When the
observer was not sure of his observation then one or more
aspects were scored as ‘‘missing’’. If the operation of a step
was not complete, for example, the nurse did not wait
before the disinfection solution to dry, that item was scored
as a ‘‘no’’. All variables were given equal weights. Scores
on the items were combined in an overall quality score to
represent the number of items that were correctly per-
formed. This overall quality score was expressed on a
0–100 quality scale. When all 47 aspects were performed
correctly, the quality score for preparation and adminis-
tration was 100. The scores ‘‘not applicable’’ and
‘‘missing’’ were not used in calculating the overall quality
score.
In addition, more general data such as date, department,
time of prescription and time of administration were col-
lected. Furthermore, characteristics of the administration
process (bolus dose injections, intermittent infusion or
continuous infusion) were always registered.
Observation
At both the pre- and post-test phases, nurses were observed
by a single observer for a maximum number of four times,
in order to include as many different nurses as possible.
During the process of preparing and administering
intravenous drugs, nurses were observed by using the
observation list. Nurses were aware of the observation but
unaware of its true purpose [20, 21].
The names of the nurses, the number of observation by
the individual nurse and the phase of the study were
registered.
Observation took place on different days of the week, at
different times of the day and night, and at both hospital
wards. The observer was present during a preset series of
shifts, to represent the variation of working hours in
nursing practice.
It was determined beforehand when intervention would
be necessary. The project team decided that in case of
preparation of the wrong drug, preparation of the wrong
dose, preparation with the wrong diluent, administration
using the wrong route and administration to the wrong
patient, the researcher should not only score the errors, but
also intervene by talking to the nurse about these poten-
tially harmful errors.
Intervention
The intervention was the implementation of the protocol
regarding the preparation and administration of intravenous
drugs at one of the departments, the intervention depart-
ment. Implementation took place, during a one-time
45 min department meeting by means of a presentation of
the pre-test results and a 15 min film with and without the
presentation of errors in the preparation and administration
of intravenous drugs. In addition, questions were answered
and current practices versus the new protocol were dis-
cussed. For instance, one of the items discussed was the
disinfecting of the hands in combination with the wearing
of gloves. Nurses thought that when they wore gloves they
do not have to disinfect their hands.
Following the presentation, the new protocol was
available to all the nurses at the ward. To give all the nurses
the opportunity to study the new protocol, the post-test took
place 2 weeks after the introduction.
Statistical analysis
At the item level, differences between the two groups and
measurements were analyzed using cross table and chi-
square tests. The standard deviations for the two groups
were not statistically different. Overall quality scores were
checked for normal distributions and satisfied this condi-
tion. For both pre- and post-test scores, potential
differences in nurses’ level quality score between the two
departments were analyzed using the independent samples
T-test for statistically significance (P B 0.05). As nurses
could be observed several times, clustering of data at the
level of nurses was present in this study. Therefore, the
mean quality scores of nurses over 1–4 observations were
Pharm World Sci (2009) 31:413–420 415
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used in the analyses of the effects of the protocol imple-
mentation. In addition, we explored the relevance of the
type of administration route for quality scores using a One
Way ANOVA technique (P B 0.05).
Ethical considerations
Approval from the local Medical Ethics Committee was
obtained.
Results
At the pre-and post-test, 132 observations were performed;
66 observations at each ward. Seventy-two nurses were
observed in the study.
In 56% of the cases, the nurses were observed at the pre-
test as well as the post-test (45% control department, 66%
intervention department). The demographic data are sum-
marized in Table 1. There were no significant differences
in any of the demographic data for the two departments.
All of the included nurses gave permission for obser-
vation by the observer.
During the study, intervening at the intervention
department was necessary on two occasions: once due to
preparation of the wrong dose during the pre-test and once
due to preparation of the wrong drug during the post-test.
In these cases, the nurses corrected their mistakes after the
observer had intervened. The mistakes were registered as
errors. Intervening at the control department was not
necessary.
Nurses working at the control department had a mean
quality score of 67 during the pre-test. Nurses from the
intervention department scored 64 at this point in time. Pre-
test scores were not significantly different for the two
nursing wards (T = 1.36, df = 55, P = 0.18). In addition,
within each department there was no significant difference
in quality scores for the administration by bolus dose
injections, intermittent infusion and continuous infusion
(a B 0.05). The mean overall quality score during the pre-
test was 66 for bolus dose injections (n = 38), 65 for
intermittent infusion (n = 76) and 66 for continuous
infusion (n = 18). The quality score for bolus dose injec-
tions differed for the two departments (T = 2.63, df = 36,
P = 0.01). At the control department the quality score for
this administration route was 71, while at the intervention
department the score was only 64. For administration by
intermittent infusion or continuous infusion, no significant
differences between the wards were found.
Fifteen variables had pre-test quality scores [90% at
both departments (Appendix). These variables referred to
the preparation of the correct drug, correct doses, making a
calculation for the solution to be made, using the right
diluent, using the prescribed quantity of this diluent, using
the prescribed method of preparation, applying the pre-
scribed administration route, keeping syringe, needles and/
or transfer needles sterile, being sure that the medication
completely dissolves, having—at the final stage—the pre-
scribed dose of the drug to be administered, administration
by the nurse who prepared the drug, administrating the
drug before the end of sell-by after preparation and
administration of the drug to the right patient.
Eight variables had pre-test scores less than 20% at both
departments (Appendix). The scores referred to checking
the expiration date, inviting colleagues to double-check the
prescription, inspecting the diluent for expiration date,
hand washing prior to preparation, using disinfectant gauze
to break/open the ampoule, mixing the acquired infusion
solution by wheeling, inspecting the solution for clarity and
inspecting the intravenous catheter for phlebitis or extra-
vasation prior to administration.
The mean quality scores of nurses at the control and
intervention department are summarized in Table 2. At
post-test, nurses at the intervention department scored
significantly better (72) than nurses at the control depart-
ment (69) (T = -2.20, df = 53, P = 0.04). At the
intervention department, significant improvement on 8
criteria (P \ 0.01) was found (Table 3).
Table 1 Pre-test (n = 57) and
post-test (n = 56) demographic
data for all nurses at the two
departments
Pre-test Post-test
Control Intervention Control Intervention
Number of nurses 26 31 Number of nurses 29 27
Male 5 5 Male 6 3
Female 21 26 Female 23 24
Mean age 37 37 Mean age 36 35
Minimum 23 23 Minimum 23 23
Maximum 58 58 Maximum 56 57
Mean years of experience 9 9 Mean years of experience 8 7
Minimum 0 1 Minimum 0 1
Maximum 32 30 Maximum 25 30
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In the post-test, 37% of the 27 observed nurses at the
intervention ward, were involved the new training. We
checked for the effects of ‘exposure to the intervention’ by
comparing the scores for nurses who did or did not attend
the protocol introduction meeting. There was a significant
difference between the mean score of nurses at the inter-
vention department who were observed during the post-test
and who had participated in the department meeting
(n = 10, score = 75) as compared to those who were
observed during the post-test but who had not attended the
meeting (n = 17, score = 70) (T = 2.27, df = 64,
P = 0.03).
Discussion
This study describes the effect of the implementation of
a protocol on the quality of care of preparation and
administration of intravenous drugs by nurses. After the
implementation of the protocol, we observed a modest
significant improvement at the intervention department,
whereas no quality improvement was found at the con-
trol ward. There are a few studies which also described
the effect of an educational intervention on the quality of
care of preparation and administration of intravenous
drugs, such as using an interactive CD-ROM pro-
gram [15] and introduction of dedicated medication
nurses [16].
However, most studies described errors in the process of
preparation and administration of intravenous drugs and
made recommendations about how to minimize the errors
[9, 10, 22].
Medication errors range from those that have little or
no impact on the patient to those with very serious
consequences. In this study, we did not assess the
clinical importance of intravenous drug errors. It is dif-
ficult to identify the clinical effects of errors because of
the delay between the occurrence and the identification
of errors and the outcome in one patient may not reflect
the likely outcomes in groups of patients as a
whole [23].
Potentially severe errors such as preparation of the
wrong doses, choosing wrong solvents and administration
of bolus doses within insufficient time, are examples of
intravenous drug errors that could be severe. They occurred
less frequently than previously reported [13].
There was a significant difference between the mean
scores of nurses at the intervention department who had
participated in the department meeting as compared to
those who had not attended the meeting. Despite that, the
post-test scores for the nurses who attended the education
session are similar to the whole post-test intervention ward
group. Perhaps the availability of, and giving attention to
the new protocol to all nurses at the ward was equal to, or
more effective than the education session itself. Alterna-
tively, carry-over effect from nurses who attended the
department meeting to nurses who were not present could
explain the lack of the difference between the two
subgroups.
Possibly the short period of implementation and the
minimum investment caused the modest improvement in
quality of care. To accomplish a major change in the atti-
tude and the competence of nurses, a more multi-faceted
strategy might be needed. Only 37% of the 27 observed
nurses at the intervention ward, were involved the new
training. Another strategy for better up take should be to
have more nurses attend the training. In addition, the
implementation could be strengthened with additional
Table 2 The quality of preparation and administration of intravenous
drugs at pre- and post-test observations (0–100 quality range)
Control department Intervention department
Pre-test Post-test Pre-test Post-test
[n] [n] [n] [n]
Mean quality score
of all nurses
67 [26] 69 [31] 64 [29] 72 [27]
Mean quality score
of nurses who were
observed at both
pre- and post-test
67 [17] 69 [23] 65 [17] 72 [23]
(Sd. 5,9) (Sd. 5,6) (Sd. 4,6) (Sd. 5,9)
Table 3 Observation items
with significant differences for
pre- and post-test at the
intervention ward in % of the
total number of observations;
n = 66 at both measurements
Variable Pre-test [n] Post-test [n] P
Inspects medication for the expiration date. 6% [52] 65% [54] 0.000
Inspects diluent for the expiration date. 0% [52] 28% [57] 0.000
Disinfects hands prior to preparation. 15% [66] 53% [66] 0.000
Breaks/opens ampoule with diluent using disinfectant gauze. 15% [61] 43% [65] 0.000
Disinfects the ampoule with medication. 83% [54] 98% [51] 0.010
Inspects the solution for clarity. 5% [66] 20% [66] 0.007
Informs the patient about administration of the drug. 76% [66] 94% [65] 0.004
Inspects the intravenous catheter for phlebitis
or extravasation prior to administration.
15% [55] 43% [65] 0.001
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methods such as improved working conditions and teach-
ing and testing of technical skills. Furthermore, it is
important to consider systems approaches to reduce me-
dication errors [24].
Observation methods for studying medication prepara-
tion and administration errors could have influenced the
results. Even when all precautions are taken to minimize
the effects of observation, it is still possible that the pres-
ence of a researcher may affect nurses’ behavior [21].
Some nurses told the observer that they miss some steps
in the total process of administration when the observer is
not there. Therefore, the error rate may have been even
higher in the absence of the researcher.
This implies that scores for the quality of the preparation
and administration of intravenous drugs in this study are
probably somewhat biased towards more positive scores.
As the procedure was identical for the two groups however,
this does not threaten the validity of the effects of the
intervention.
Prudence is called for when generalizing the results to
other departments or other hospitals. The two departments,
which were involved in this study, are departments where
the incidence of preparation and administration of intra-
venous drugs is high. Both departments were internal
medicine departments where doctors and nurses often treat
patients with infectious diseases. Possibly, the nurses at
these departments are more aware of the importance of
hygiene and infection prevention than nurses at other
departments.
Conclusions
The number of errors in the preparation and administration
of intravenous drugs is high. Our study identified an
unobtrusive significant difference between pre-test and
post-test quality of preparation and administration of these
drugs after the implementation of a new protocol. There-
fore, we conclude that even with limited means and
investments, the quality of the preparation and adminis-
tration of intravenous drugs can be improved. The protocol
developed during the pre-intervention period contributes to
the improvement of the quality of preparation and admin-
istration of intravenous drugs in nursing practice.
Given the limited quality of the preparation and
administration process, investing more time and money in
attempts at improvement seems justified. Without these
attempts, the need for patient safety in everyday patient
care might be insufficiently met.
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Scores in % of all observation items per measurement and department
Variable 1st measurement 2nd measurement
N contr (%) int (%) S* N contr (%) int (%) S*
1. Correct drug 132 100 100 - 132 100 99 -
2. Correct doses 132 100 99 - 132 100 100 -
3. Inspects medication for the expiration date s 99 11 6 - 103 8 65 ?
4. Asks colleague to double-check the prescription 57 15 3 - 44 10 4 -
5. Looks up preparation procedure in a handbook 132 53 24 ? 132 50 17 ?
6. Makes a calculation for the solution to be made 4 100 100 - 2 – 50 -
7. Ask colleague to double-check calculation 4 0 67 - 1 – 100 -
8. Gets the right diluent 117 98 95 - 124 100 98 -
9. Inspects the diluent for the expiration date s 102 2 0 - 109 0 28 ?
10. Washes hands prior to preparation 132 3 14 - 132 9 24 -
11. Disinfects hands prior to preparation s 132 49 15 ? 132 38 53 -
12. Wears gloves during preparation 132 39 24 - 132 50 27 ?
13. Uses disinfectant gauze to break/open the ampoule s 102 5 15 - 115 6 43 ?
14. Disinfects the ampoule with medication s 112 86 83 - 111 87 98 -
15. Waits for the disinfection solution to dry 95 86 67 - 102 81 88 -
Appendix
418 Pharm World Sci (2009) 31:413–420
123
References
1. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a
safer health system. Washington DC: National academy press; 2000.
2. Leape LL, Berwick DM, Bates DW. What practices will most
improve safety? Evidence-based medicine meets patient safety.
JAMA. 2002;288(4):501–7. doi:10.1001/jama.288.4.501.
3. Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemi-
ology of medical error. BMJ. 2000;320(7237):774–7. doi:
10.1136/bmj.320.7237.774.
4. Kuitunen T, Kuisma P, Hoppu K. Medication errors made by
health care professionals. Analysis of the Finnish Poison Infor-
mation Centre data between 2000 and 2007. Eur J Clin
Pharmacol. 2008;64(8):769–74. doi:10.1007/s00228-008-0496-4.
continued
Variable 1st measurement 2nd measurement
N contr (%) int (%) S* N contr (%) int (%) S*
16. Disinfects injection point of infusion bag 83 82 91 - 68 90 78 -
17. Waits for the disinfectant to dry 71 76 53 - 58 68 52 -
18. Uses the prescribed quantity of solvent 119 98 98 - 124 100 100 -
19. Uses the prescribed method of preparation 130 98 100 - 131 100 100 -
20. Uses the prescribed administration process 132 100 100 - 132 100 100 -
21. Keeps syringe, needles and/or transfer needles sterile 127 98 92 - 131 99 100 -
22. Takes care that the medicine completely dissolves 106 96 93 - 116 98 97 -
23. Mixes the acquired infusion solution by wheeling 118 11 7 - 124 24 21 -
24. Inspects the solution for clarity s 132 0 5 - 132 0 20 ?
25. Has—at the final stage—the prescribed dose of the drug to be administered 132 94 91 - 132 97 99 -
26. Puts a completely filled out label on the infusion bag/syringe 97 7 30 - 76 19 10 -
27. Gets NaCl 0.9% to flush the infusion system (because of incompatibility
of the medicine with the infusion solution)
30 86 96 - 37 100 100 -
28. Keeps syringe, needles and/or transfer needles sterile 84 100 96 - 76 100 100 -
29. Writes his/here initials in the medication administration system 132 94 86 - 130 97 97 -
30. Writes the deviate time of administration in the medication administration system 30 78 75 - 8 80 67 -
31. Administration done by the nurse who prepared the drug 131 100 94 - 129 97 100 -
32. Administrates the drug before the end of sell by after preparation 129 99 98 - 124 98 100 -
33. Inform the patient about administration of the drug s 132 71 76 - 129 72 94 ?
34. Administrates the drug to the right patient 132 100 100 - 129 100 100 -
35. Inspects the IV infusion system for phlebitis and/or extravasation prior
to administration s
116 10 15 - 129 25 43 -
36. Arranges for new infusion needle in case of phlebitis/extravasation 2 – 50 - 1 0 – -
37. Disinfects the injection point of the infusion system or the infusion needle 93 83 96 - 94 95 97 -
38. Waits for the disinfectant to dry 84 35 20 - 90 37 32 -
39. Rinses out the drip with compatible infusion solution 33 100 83 - 36 83 75 -
40. Uses a new coupling 75 67 96 ? 54 58 91 ?
41. Administrates the medication using the prescribed administration time 130 89 61 ? 128 80 66 -
42. Regulates the controller according to the described rate 85 95 87 - 69 100 100 -
43. Keeps needles, coupling and/or drip sterile 129 97 100 - 129 100 100 -
44. Administers all of the solution with medicine 113 88 96 - 108 100 97 -
45. Rinses out the drip with compatible infusion solution 109 43 63 - 89 56 76 -
46. Describes the medication administered on the patient list in case
of short stay or continued infusion
96 82 78 - 73 80 61 -
47. Stays in the patient’s room after administrating the drug 116 21 18 - 110 30 25 -
* = observation item with significant differences for the control department and the intervention department
s = observation item with significant differences for pre- and post-test at the intervention department
contr = control department
int = intervention department
Pharm World Sci (2009) 31:413–420 419
123
5. Ashcroft DM, Cooke J. Retrospective analysis of medication
incidents reported using an on-line reporting system. Pharm
World Sci. 2006;28(6):359–65. doi:10.1007/s11096-006-9040-8.
6. Fry MM, Dacey C. Factors contributing to incidents in medicine
administration. Part 2. Br J Nurs. 2007;16(11):676–81.
7. Fry MM, Dacey C. Factors contributing to incidents in medicine
administration. Part 1. Br J Nurs. 2007;16(9):556–8.
8. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA,
et al. The costs of adverse drug events in hospitalized patients
Adverse Drug Events Prevention Study Group. JAMA. 1997;
277(4):307–11. doi:10.1001/jama.277.4.307.
9. Hartley GM, Dhillon S. An observational study of the prescribing
and administration of intravenous drugs in a general hospital. Int
J Pharm Pract. 1998;6:38–45.
10. Ross LM, Wallace J, Paton JY. Medication errors in a pediatric
teaching hospital in the UK: five years operational experience.
Arch Dis Child. 2000;83(6):492–7. doi:10.1136/adc.83.6.492.
11. Taxis K, Barber N. Ethnographic study of incidence and severity
of intravenous drug errors. BMJ. 2003;326(7391):684. doi:
10.1136/bmj.326.7391.684.
12. Cousins DH, Sabatier B, Begue D, Schmitt C, Hoppe-Tichy T.
Medication errors in intravenous drug preparation and adminis-
tration: a multicentre audit in the UK, Germany and France. Qual
Saf Health Care. 2005;14(3):190–5. doi:10.1136/qshc.2003.006
676.
13. Konick-McMahan J. Full speed ahead–with caution: pushing
intravenous medications. Nursing. 1996;26(6):26–31.
14. Anselmi ML, Peduzzi M, Dos Santos CB. Errors in the administra-
tion of intravenous medication in Brazilian hospitals. J Clin Nurs.
2007;16(10):1839–47. doi:10.1111/j.1365-2702.2007.01834.x.
15. Schneider PJ, Pedersen CA, Montanya KR, Curran CR, Harpe
SE, Bohenek W, et al. Improving the safety of medication
administration using an interactive CD-ROM program. Am J
Health Syst Pharm. 2006;63(1):59–64. doi:10.2146/ajhp040609.
16. Greengold NL, Shane R, Schneider P, Flynn E, Elashoff J,
Hoying CL, et al. The impact of dedicated medication nurses on
the medication administration error rate: a randomized controlled
trial. Arch Intern Med. 2003;163(19):2359–67. doi:10.1001/
archinte.163.19.2359.
17. Keen JH. Slow down. J Emerg Nurs. 1995;21(4):323–6. doi:
10.1016/S0099-1767(05)80065-0.
18. McConnel EA. Administering an I V push injection through an
existing peripheral line. Nursing. 1996;26(8):24.
19. Whitman M. The push is on: delivering medications safely by i v
bolus. Nursing. 1995;25(8):52–4.
20. van den Bemt PM, Fijn R, van der Voort PH, Gossen AA, Egberts
TC, Brouwers JR. Frequency and determinants of drug admin-
istration errors in the intensive care unit. Crit Care Med.
2002;30(4):846–50. doi:10.1097/00003246-200204000-00022.
21. Dean B, Barber N. Validity and reliability of observational
methods for studying medication administration errors. Am J
Health Syst Pharm. 2001;58(1):54–9.
22. O’hare MC, Bradley AM, Gallagher T, Shields MD. Errors in
administration of intravenous drugs. BMJ. 1995;310(6):1536–7.
23. Dean BS, Barber ND. A validated, reliable method of scoring the
severity of medication errors. Am J Health Syst Pharm. 1999;
56(1):57–62.
24. Anderson DJ, Webster CS. A systems approach to the reduction
of medication error on the hospital ward. J Adv Nurs. 2001;
35(1):34–41. doi:10.1046/j.1365-2648.2001.01820.x.
420 Pharm World Sci (2009) 31:413–420
123
